Polymorphism in the cagA EPIYA motif impacts development of gastric cancer

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 959-968

  Jones, Kathleen R ^a   Joo, Young Min ^b   Jang, Sungil ^b   Yoo, Yun Jung ^b   Lee, Hak Sung ^c   Chung, In Sik ^c   Olsen, Cara H ^d   Whitmire, Jeannette M ^a   Merrell, D Scott ^a   Cha, Jeong Heon ^b,e  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Oral Science Research Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Uniformed Services University of the Health Sciences   (United States)

^e Yonsei University College of Dentistry   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; VIRULENCE FACTOR; BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAGA GENE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; FEMALE; GASTRITIS; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN MOTIF; SOUTH KOREA; STOMACH CANCER; AMINO ACID SEQUENCE; DNA SEQUENCE; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; KOREA; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; STOMACH TUMOR;

HELICOBACTER PYLORI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HELICOBACTER PYLORI; HUMANS; KOREA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 65249157013     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02330-08     Document Type: Article

References (49)

1. Ahn, Y. O., B. J. Park, K. Y. Yoo, N. K. Kim, D. S. Heo, J. K. Lee, H. S. Ahn, D. H. Kang, H. Kim, M. S. Lee, et al. 1991. Incidence estimation of stomach cancer among Koreans. J. Korean Med. Sci. 6:7-14.
2. Amieva, M. R., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4:677-690.
3. Amieva, M. R., R. Vogelmann, A. Covacci, L. S. Tompkins, W. J. Nelson, and S. Falkow. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430-1434.
4. Argent, R. H., J. L. Hale, E. M. El-Omar, and J. C. Atherton. 2008. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J. Med. Microbiol. 57:1062-1067.
5. Argent, R. H., M. Kidd, R. J. Owen, R. J. Thomas, M. C. Limb, and J. C. Atherton. 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127:514-523.
6. Argent, R. H., R. J. Thomas, F. Aviles-Jimenez, D. P. Letley, M. C. Limb
7. E. M. El-Omar, and J. C. Atherton. 2008. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H pylori virulence evolves in these families. Clin. Cancer Res. 14:2227-2235.
8. Argent, R. H., Y. Zhang, and J. C. Atherton. 2005. Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J. Clin. Microbiol. 43:791795.
9. Azuma, T., A. Yamakawa, S. Yamazaki, K. Fukuta, M. Ohtani, Y. Ito, M. Dojo, Y. Yamazaki, and M. Kuriyama. 2002. Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 186:1621-1630.
10. Azuma, T., S. Yamazaki, A. Yamakawa, M. Ohtani, A. Muramatsu, H. Suto, Y. Ito, M. Dojo, Y. Yamazaki, M. Kuriyama, Y. Keida, H. Higashi, and M. Hatakeyama. 2004. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189:820-827.
11. Backhed, F., E. Torstensson, D. Seguin, A. Richter-Dahlfors, and B. Rokbi. 2003. Helicobacter pylori infection induces interleukin-8 receptor expression in the human gastric epithelium. Infect. Immun. 71:3357-3360.
12. Blaser, M. J. 1998. Helicobacter pylori and gastric diseases. BMJ 316:15071510.
13. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:21112115.
14. Bourzac, K. M., L. A. Satkamp, and K. Guillemin. 2006. The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus. Infect. Immun. 74:25372543.
15. Carpenter, B. M., T. K. McDaniel, J. M. Whitmire, H. Gancz, S. Guidotti, S. Censini, and D. S. Merrell. 2007. Expanding the Helicobacter pylori genetic toolbox: modification of an endogenous plasmid for use as a transcriptional reporter and complementation vector. Appl. Environ. Microbiol. 73:75067514.
16. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.
17. Choi, K. D., N. Kim, D. H. Lee, J. M. Kim, J. S. Kim, H. C. Jung, and I. S. Song. 2007. Analysis of the 3' variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Dig. Dis. Sci. 52:960-966.
18. Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, et al. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791-5795.
19. Crew, K. D., and A. I. Neugut. 2006. Epidemiology of gastric cancer. World J. Gastroenterol. 12:354-362.
20. Ernst, P. B., and B. D. Gold. 2000. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54:615-640.
21. The EUROGAST Study Group. 1993. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 34:1672-1676.
22. Galgani, M., I. Busiello, S. Censini, S. Zappacosta, L. Racioppi, and R. Zarrilli. 2004. Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect. Immun. 72:4480-4485.
23. Gwack, J., A. Shin, C. S. Kim, K. P. Ko, Y. Kim, J. K. Jun, J. Bae, S. K. Park, Y. C. Hong, D. Kang, S. H. Chang, H. R. Shin, and K. Y. Yoo. 2006. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br. J. Cancer 95:639-641.
24. Higashi, H., A. Nakaya, R. Tsutsumi, K. Yokoyama, Y. Fujii, S. Ishikawa, M. Higuchi, A. Takahashi, Y. Kurashima, Y. Teishikata, S. Tanaka, T. Azuma, and M. Hatakeyama. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279:17205-17216.
25. Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99:14428-14433.
26. Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686.
27. International Agency for Research on Cancer. 1994. Infection with Helicobacter pylori, p. 177-240. Monographs on the evaluation of carcinogenic risks to humans, vol. 61. International Agency for Research on Cancer, Lyon, France.
28. Kim, J. M., J. S. Kim, H. C. Jung, I. S. Song, and C. Y. Kim. 2000. Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence the clinical outcome. J. Gastroenterol. 35:898-906.
29. Matysiak-Budnik, T., and F. Megraud. 1997. Epidemiology of Helicobacter pylori infection with special reference to professional risk. J. Physiol. Pharmacol. 48 (Suppl. 4) :3-17.
30. Neel, B. G., H. Gu, and L. Pao. 2003. The 'Shp'ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284-293.
31. Neugut, A. I., M. Hayek, and G. Howe. 1996. Epidemiology of gastric cancer. Semin. Oncol. 23:281-291.
32. Nguyen, L. T., T. Uchida, K. Murakami, T. Fujioka, and M. Moriyama. 2008. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J. Med. Microbiol. 57:1445-1453.
33. Parkin, D. M., F. Bray, J. Ferlay, and P. Pisani. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108.
34. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
35. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1267-1271.
36. Roder, D. M. 2002. The epidemiology of gastric cancer. Gastric Cancer 5 (Suppl. 1) :5-11.
37. Roovers, K., and R. K. Assoian. 2000. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22:818-826.
38. Rudi, J., C. Kolb, M. Maiwald, D. Kuck, A. Sieg, P. R. Galle, and W. Stremmel. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36:944-948.
39. Salih, B. A., M. F. Abasiyanik, N. Bayyurt, and E. Sander. 2007. H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study. World J. Gastroenterol. 13:3245-3248.
40. Satomi, S., A. Yamakawa, S. Matsunaga, R. Masaki, T. Inagaki, T. Okuda, H. Suto, Y. Ito, Y. Yamazaki, M. Kuriyama, Y. Keida, H. Kutsumi, and T. Azuma. 2006. Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J. Gastroenterol. 41: 668-673.
41. Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559-14564.
42. Shin, A., H. R. Shin, D. Kang, S. K. Park, C. S. Kim, and K. Y. Yoo. 2005. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br. J. Cancer 92:1273-1275.
43. Stein, M., F. Bagnoli, R. Halenbeck, R. Rappuoli, W. J. Fantl, and A. Covacci. 2002. c-Src/Lyn kinases activate Helicobacter pyloriCagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:971-980.
44. Talley, N. J., A. R. Zinsmeister, A. Weaver, E. P. DiMagno, H. A. Carpenter, G. I. Perez-Perez, and M. J. Blaser. 1991. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83:1734-1739.
45. Tokudome, S., R. Ando, R. Ghadimi, T. Tanaka, N. Hattori, Z. Yang, M. Marumoto, H. Agawa, K. Arakawa, Y. Osaka, H. Tanaka, A. Hosono, and M. A. Moore. 2007. Are there any real Helicobacter pylori infection-negative gastric cancers in Asia? Asian Pac. J. Cancer Prev. 8:462-463.
46. Tsutsumi, R., H. Higashi, M. Higuchi, M. Okada, and M. Hatakeyama. 2003. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278:3664-3670.
47. Tsutsumi, R., A. Takahashi, T. Azuma, H. Higashi, and M. Hatakeyama. 2006. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 26:261-276.
48. Yamamoto, S. 2001. Stomach cancer incidence in the world. Jpn. J. Clin. Oncol. 31:471.
49. Yamaoka, Y., H. M. El-Zimaity, O. Gutierrez, N. Figura, J. G. Kim, T. Kodama, K. Kashima, and D. Y. Graham. 1999. Relationship between the cagA 3 repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117:342-349.